Eldorado Gold Corporation (TSX:ELD)

Verve Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,079	856.8	540.47	279.74	481.33	451.96
Short-Term Investments	-	138.93	2.83	35.14	0.16	59.23
Cash & Short-Term Investments	1,079	995.73	543.31	314.87	481.49	511.19
Cash Growth	80.64%	83.27%	72.55%	-34.60%	-5.81%	176.55%
Accounts Receivable	75.19	57.83	49.39	33.75	23.02	35.65
Other Receivables	80.47	52.11	51.7	33.29	27.73	18.01
Receivables	155.66	109.94	101.09	67.04	50.75	53.66
Inventory	290.36	279	235.89	198.87	178.16	164.14
Prepaid Expenses	19.74	20.73	20	23.94	17.83	19.36
Other Current Assets	77.99	76.74	30.13	27.74	-	5.75
Total Current Assets	1,622	1,482	930.41	632.46	728.24	754.1
Property, Plant & Equipment	4,424	4,119	3,756	3,596	4,003	4,042
Long-Term Investments	43.45	33.24	105.97	61.61	59.85	-
Goodwill	92.59	92.59	92.59	92.59	92.59	92.59
Long-Term Deferred Tax Assets	19.49	19.49	14.75	14.51	-	-
Long-Term Deferred Charges	2.79	3.49	3.18	1.49	2.02	2.19
Other Long-Term Assets	99.47	85.87	85.19	59	44.83	39.47
Total Assets	6,304	5,836	4,988	4,458	4,931	4,931
Accounts Payable	409.31	112.58	93.33	74.91	71.01	65.06
Accrued Expenses	-	179.01	127.82	112.68	105.14	103.32
Current Portion of Long-Term Debt	-	-	-	-	-	66.67
Current Portion of Leases	5.94	4.69	5.02	4.78	7.23	11.3
Current Income Taxes Payable	-	66.2	23.95	4.12	19.18	11
Current Unearned Revenue	-	8.89	8.94	-	-	-
Other Current Liabilities	86.6	40.79	15.17	14.46	4.09	4.7
Total Current Liabilities	501.85	412.17	274.22	210.94	206.65	262.04
Long-Term Debt	1,157	915.43	636.06	494.41	489.76	434.47
Long-Term Leases	10.51	10.03	12.09	12.16	14.9	14.66
Long-Term Deferred Tax Liabilities	347.98	434.94	399.11	424.73	439.2	414.55
Other Long-Term Liabilities	187.89	163.67	143.93	105.89	131.37	106.68
Total Liabilities	2,217	1,947	1,476	1,257	1,291	1,244
Common Stock	3,423	3,434	3,413	3,242	3,225	3,145
Additional Paid-In Capital	2,583	2,613	2,617	2,618	2,615	2,638
Retained Earnings	-1,879	-2,193	-2,488	-2,593	-2,239	-2,103
Treasury Stock	-9.16	-12.97	-19.26	-20.45	-10.29	-11.45
Comprehensive Income & Other	-21.07	56.18	-4.75	-42.28	-20.91	-21.82
Total Common Equity	4,097	3,897	3,518	3,204	3,570	3,646
Minority Interest	-10.53	-8.14	-6.18	-3.2	69.56	40.87
Shareholders' Equity	4,086	3,888	3,512	3,201	3,640	3,687
Total Liabilities & Equity	6,304	5,836	4,988	4,458	4,931	4,931
Total Debt	1,174	930.15	653.17	511.36	511.89	527.09
Net Cash (Debt)	-51.57	98.82	-3.9	-134.87	29.45	-15.9
Net Cash Per Share	-0.25	0.48	-0.02	-0.74	0.16	-0.09
Filing Date Shares Outstanding	203.55	204.6	202.38	183.87	182.4	174.37
Total Common Shares Outstanding	203.55	204.6	202.38	183.87	182.4	174.37
Working Capital	1,120	1,070	656.19	421.52	521.59	492.06
Book Value Per Share	20.13	19.04	17.38	17.43	19.57	20.91
Tangible Book Value	4,004	3,804	3,426	3,111	3,478	3,554
Tangible Book Value Per Share	19.67	18.59	16.93	16.92	19.07	20.38
Land	-	263.95	241.51	228.65	218.65	244.13
Machinery	-	2,849	2,742	2,604	2,533	2,384
Construction In Progress	-	119.17	112.54	123.61	109.81	83.51

Source: S&P Global Market Intelligence. Standard template. Financial Sources.